Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Aug 9, 2011
Company's fully covered metal stent now approved in Canada for use in treating benign biliary strictures
-
Aug 8, 2011
U.S. Court of Appeals for the First Circuit has affirmed the dismissal of a securities fraud case in connection with the 2004 recall of the TAXUS® Express2 Paclitaxel-Eluting Coronary Stent System
-
Aug 8, 2011
Investment supported by grant funding from Government through IDA Ireland
-
Jul 28, 2011
Company also announces new share repurchase, China investment and restructuring program
-
Jul 28, 2011
"This repurchase program reflects our confidence in the strength of the Company's long-term business prospects, earnings growth potential and our ability to generate strong cash flow," said Ray Elliott, President and CEO
-
Jul 27, 2011
Investment to support development of local manufacturing capabilities and training center
-
Jul 21, 2011
Fitch Ratings upgrades Company's corporate credit rating to an investment grade rating, BBB-, with a stable outlook
-
Jul 14, 2011
Boston Scientific will webcast its conference call with financial results and business highlights for Q2 2011 on Thursday, July 28. Learn how to tune in.
-
Jul 12, 2011
European ASTI study to evaluate new nitinol stent to treat carotid artery disease
-
Jul 5, 2011Boston Scientific's Galway Site in Ballybrit Commercializes Innovative Mustang™ PTA Balloon Catheter
Recently-launched PTA catheter, designed for a wide range of peripheral angioplasty procedures, expected to be site’s biggest launch this year
-
Jul 4, 2011
Expanded Heredia plant to manufacture a broad line of medical devices
-
Jun 30, 2011
Comprehensive identifies pain as a major US health problem and lays the foundation for chronic pain care, research and education for the next decade.
-
Jun 30, 2011Detachable coils for peripheral embolization offer precise placement and control in coiling procedures
System had earlier received FDA clearance and CE Mark approval for obstructing or reducing blood flow in the peripheral vasculature during embolization procedures.
-
Jun 27, 2011
Bipartisan bill is intended to modernize the U.S. patent system
-
Jun 20, 2011
Low-profile, high-pressure balloon offers physicians exceptional performance in a single platform for peripheral angioplasty procedures
-
Jun 16, 2011
Company will participate in the healthcare conference on June 22 in Boston. Learn how to watch the webcast or replay.
-
Jun 7, 2011
Patents relate to coatings (drug and polymer) for drug-eluting stents
-
May 27, 2011
Action affects products distributed in U.S. and its territories; Atlantis® SR Pro available immediately as a substitute
-
May 25, 2011
Boston Scientific becomes the first and only company to offer two distinct drug-eluting stents to treat small vessels
-
May 23, 2011
New technology designed to improve lead anchoring for physicians to be introduced at INS World Congress
-
May 20, 2011
12-month clinical data demonstrate low adverse event rates for Boston Scientific's 2.25 mm PROMUS Element Platinum Chromium Stent
-
May 18, 2011
Results for Boston Scientific WATCHMAN device presented at EuroPCR
-
May 16, 2011
Five-year data from RISA Trial presented at ATS adds to clinical evidence showing long-term safety of Boston Scientific's Alair® Bronchial Thermoplasty System
-
May 11, 2011
Jury in the District of Delaware found that Cordis owed Boston Scientific approximately $19.5 million for infringing its Jang patent.
-
May 11, 2011
Patients receive first device-based treatment for severe asthma